TAK

Q: What is the price of Takeda Pharmaceutical (TAK) today?

The price of Takeda Pharmaceutical (TAK) today is US$ 13,71, with a variation of 0.31% compared to the last year. The price of Takeda Pharmaceutical (TAK) started the year trading around US$ 13,24 and today it is at US$ 13,71. Follow the real-time price chart, the historical price of Takeda Pharmaceutical (TAK), and stock data from Ibovespa and international markets.

Q: When does Takeda Pharmaceutical (TAK) pay dividends?

In the last year, Takeda Pharmaceutical (TAK) distributed dividends in the month of July, totaling US$ 0,34. The Dividend Yield for the last 12 months is 4,60%.

Q: Takeda Pharmaceutical (TAK) is it worth it?

Currently, Takeda Pharmaceutical (TAK) is priced at US$ 13,71, with a P/E of 38,64%, representing a deviation of 30,39% from its historical average P/E. In the last year, the stock showed a variation of 0.31% in its price and distributed US$ 0,34 in dividends, resulting in a Dividend Yield of 4,60%. The total shareholder return was 0,31%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Takeda Pharmaceutical (TAK)?

Investing in stocks of Takeda Pharmaceutical (TAK) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Takeda Pharmaceutical (TAK) yield today?

The yield of Takeda Pharmaceutical (TAK) was -10,33% in the last month, 0,31% in the last year and -4,28% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,67 in dividends, um Dividend Yield de 4,60%.If you wanted to buy 100 stocks of Takeda Pharmaceutical (TAK) today, the total investment would be US$ 1.371,00, based on the current price of US$ 13,71.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 1.375,25In 5 years: US$ 1.312,32In 10 years: 1.251,45It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Takeda Pharmaceutical Co. Ltd.

Price

US$ 13,71

variation (12m)

0,31%

p/l

38,64

p/vp

0,96

DIVIDEND YIELD

4,60%

price TAK

BVMF

TAK

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of TAK

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-10,33%

3 months

-6,61%

1 year

0,31%

2 years

-2,25%

5 years

-4,28%

10 years

-8,72%

real profitability

profitability minus inflation.

1 month

-10,33%

3 months

-6,95%

1 year

-4,09%

2 years

-10,78%

5 years

-29,27%

10 years

-45,35%

Indicators TAK

check out the fundamentals of Takeda Pharmaceutical shares

P/E

38,64

Sector: -1,19 Industry: -3,13

P/SALES RATIO (PSR)

1,53

Sector: 1,95 Industry: 2,78

P/BV

0,96

Sector: 2,22 Industry: 1,88

DIVIDEND YIELD (DY)

4,60%

Sector: - Industry: -

ROA

1,22%

Sector: -26,82% Industry: -52,06%

ROE

2,49%

Sector: -29,98% Industry: -40,51%

ROIC

4,63%

Sector: -411,56% Industry: -412,66%

NET MARGIN

3,96%

Sector: -27,32% Industry: -30,04%

GROSS MARGIN

64,46%

Sector: 43,14% Industry: 44,05%

OPERATING MARGIN

6,39%

Sector: -23,36% Industry: -26,70%

P/EBITDA

5,28

Sector: 0,02 Industry: -2,09

P/EBIT

12,82

Sector: -1,26 Industry: -2,90

P/ASSET

0,47

Sector: 1,27 Industry: 1,41

BVPS

15,19

Sector: 3,73 Industry: 1,64

EPS

0,38

Sector: -0,77 Industry: -1,17

EQUITY / ASSETS

0,49

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

-0,42%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-7,36%

Sector: - Industry: -

FAIR PRICE OF Takeda Pharmaceutical ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 13,71

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-16,88%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

TAK indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%

comparison of TAK with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History TAK

current DY: 4,60%

5-year average DY: 5,24%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	31/03/2025	07/07/2025	0,33900000
Dividends	30/09/2024	12/12/2024	0,33300000
Dividends	28/03/2024	08/07/2024	0,29220000
Dividends	29/09/2023	11/12/2023	0,31910000
Dividends	31/03/2023	10/07/2023	0,26900000
Dividends	30/09/2022	12/12/2022	0,30120000
Dividends	31/03/2022	11/07/2022	0,33010000
Dividends	30/09/2021	13/12/2021	0,39690000
Dividends	31/03/2021	12/07/2021	0,40660000
Dividends	30/09/2020	11/12/2020	0,43050000
Dividends	31/03/2020	06/07/2020	0,41900000
Dividends	30/09/2019	12/12/2019	0,41110000
Dividends	29/03/2019	10/07/2019	0,41720000
Dividends	28/09/2018	13/12/2018	0,39550000
Dividends	29/03/2018	09/07/2018	0,40640000
Dividends	29/09/2017	11/12/2017	0,39950000
Dividends	31/03/2017	10/07/2017	0,39890000
Dividends	30/09/2016	12/12/2016	0,39240000
Dividends	31/03/2016	11/07/2016	0,43700000
Dividends	30/09/2015	11/12/2015	0,36530000
Dividends	31/03/2015	09/07/2015	0,36530000
Dividends	29/09/2014	11/12/2014	0,37830000
Dividends	28/03/2014	10/07/2014	0,44370000
Dividends	27/09/2013	12/12/2013	0,43700000
Dividends	28/03/2013	08/07/2013	0,45710000
Dividends	27/09/2012	13/12/2012	0,54600000
Dividends	29/03/2012	09/07/2012	0,56380000
Dividends	29/09/2011	12/12/2011	0,57860000
Dividends	30/03/2011	07/07/2011	0,55580000
Dividends	29/09/2010	13/12/2010	0,53320000
Dividends	29/09/2009	15/12/2009	0,51780000
Dividends	30/03/2009	14/07/2009	0,48180000
Dividends	29/09/2008	16/12/2008	0,46810000

ABOUT THE COMPANY Takeda Pharmaceutical

Takeda Pharmaceutical Co. Ltd.

Average user rating I10

4.0 (9 people)

Estados Unidos

100 years

Foundation: 1925

2010

Year of debut on the stock exchange - 15 years

47.495

Employees

The Company Takeda Pharmaceutical Co. Ltd. (Estados Unidos), is listed on NYSE with a market value of $ 45,68 Billions, having a net worth of $ 47,52 Billions.

With a total of 47.495 employees, the company is listed in the sector of Health and categorized in industry of Main Medications.

In the last 12 months the Company had a revenue of $ 29,82 Billions, which generated a profit in the amount of $ 1,18 Billion.

As for its main indicators, the Company has a P/E ratio of 38,64, a P/BV ratio of 0,96 and in the last 12 months the dividend yield of TAK was at 4,60%.

The Company is traded internationally through the ticker TAK.

Market value

US$ 45,68 Billions

Net worth

US$ 47,52 Billions

US$ 47.522.240.000,00

Assets

US$ 96,93 Billions

US$ 96.928.280.000,00

Total Number of Shares

3,13 Billions

3.129.000.000

Average Daily Trading Volume

US$ 3,83 Milhões

US$ 3.828.554,56

Sector

Health

Industry

Main Medications

TAK

TAK revenue and profits

TAK results

DRAG THE FRAME TO SEE MORE DATA

TAK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12 M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12 M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12 M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12 M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12 M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12 M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12 M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

Frequently Asked Questions

What is the price of Takeda Pharmaceutical (TAK) today?

The price of Takeda Pharmaceutical (TAK) today is US$ 13,71, with a variation of 0.31% compared to the last year. The price of Takeda Pharmaceutical (TAK) started the year trading around US$ 13,24 and today it is at US$ 13,71. Follow the real-time price chart, the historical price of Takeda Pharmaceutical (TAK), and stock data from Ibovespa and international markets.

When does Takeda Pharmaceutical (TAK) pay dividends?

In the last year, Takeda Pharmaceutical (TAK) distributed dividends in the month of July, totaling US$ 0,34. The Dividend Yield for the last 12 months is 4,60%.

Takeda Pharmaceutical (TAK) is it worth it?

Currently, Takeda Pharmaceutical (TAK) is priced at US$ 13,71, with a P/E of 38,64%, representing a deviation of 30,39% from its historical average P/E. In the last year, the stock showed a variation of 0.31% in its price and distributed US$ 0,34 in dividends, resulting in a Dividend Yield of 4,60%. The total shareholder return was 0,31%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Takeda Pharmaceutical (TAK)?

Investing in stocks of Takeda Pharmaceutical (TAK) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Takeda Pharmaceutical (TAK) yield today?

The yield of Takeda Pharmaceutical (TAK) was -10,33% in the last month, 0,31% in the last year and -4,28% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,67 in dividends, um Dividend Yield de 4,60%.

If you wanted to buy 100 stocks of Takeda Pharmaceutical (TAK) today, the total investment would be US$ 1.371,00, based on the current price of US$ 13,71.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 1.375,25
In 5 years: US$ 1.312,32
In 10 years: 1.251,45

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TAK

Takeda Pharmaceutical Co. Ltd.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of TAK

check out the fundamentals of Takeda Pharmaceutical shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 4,60%

5-year average DY: 5,24%

type

date with

payment date

value

ABOUT THE COMPANY Takeda Pharmaceutical

Takeda Pharmaceutical Co. Ltd.

Estados Unidos

100 years

2010

47.495

PROFIT X PRICE TAK

TAK results

TAK cash flow

evolution of assets - TAK

TAK balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions